Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.
Research context
Sequent Scientific Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Sequent Scientific Limited is currently in a long term uptrend where the price is trading 26.3% above its 200 day moving average.
From a valuation standpoint, the stock is 6.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
Sequent Scientific Limited's total revenue rose by 13.2% to $4B since the same quarter in the previous year.
Its net income has increased by 83.3% to $372M since the same quarter in the previous year.
Finally, its free cash flow grew by 203.1% to $843M since the same quarter in the previous year.
Based on the above factors, Sequent Scientific Limited gets an overall score of 5/5.